Hospice Patient Denied Pain Relief for Nearly Two Days
The August 2024 inspection revealed that Resident 76, a cognitively intact hospice patient with alcoholic cirrhosis of the liver and congestive heart failure, went without his prescribed Dilaudid from Saturday afternoon until Monday morning. The resident had been receiving the powerful narcotic pain medication at least five times daily to manage breakthrough pain not covered by his Fentanyl patch.
According to inspection records, the resident received his last dose of Dilaudid at 4:00 PM on August 17, 2024. Despite multiple requests from the resident and reports from nursing assistants about his severe pain, the facility failed to obtain the medication or provide alternatives until 8:00 AM on August 19, 2024.
The resident told inspectors he was in such severe pain over the weekend that he could not eat much of his meals, and at times could not eat at all. He experienced nausea and anxiety severe enough to require anti-anxiety medication (Ativan) and anti-nausea medication (Phenergan).
Staff Witnessed Suffering but Failed to Act
Multiple staff members documented the resident's distress. A certified nursing aide reported that on Saturday evening, the resident asked him "three or four times" to notify the nurse about his pain and request for medication. The aide observed the resident grunting at the end of sentences, moaning, and showing facial grimacing. On Sunday, the resident repeatedly pressed his call light, holding his stomach each time while requesting pain medication.
Another aide reported finding the resident in too much pain to eat dinner Saturday night, noting this was highly unusual as the resident "never missed a meal, even if it was eating a peanut butter sandwich."
Despite these clear signs of suffering, nursing staff failed to follow standard protocols. The licensed practical nurse who administered the last available dose admitted she did not notify the physician or hospice services about the medication shortage, stating "it's my fault" during the investigation. She acknowledged this violated facility practice and that it was crucial for hospice residents to have their end-of-life medications available.
Medical Implications of Withheld Pain Management
For a patient with end-stage liver cirrhosis and an inoperable hernia, the absence of breakthrough pain medication for 40 hours represents a serious medical failure. Dilaudid (hydromorphone) is approximately eight times more potent than morphine and is specifically prescribed for severe pain that cannot be managed by other medications alone.
In hospice care, maintaining comfort is the primary medical goal. When breakthrough pain medications are withheld, patients can experience not only physical suffering but also psychological distress. Uncontrolled pain triggers a cascade of physiological responses including elevated heart rate, increased blood pressure, and stress hormone release - particularly dangerous for someone with congestive heart failure.
The facility's Medical Director, who also served as the resident's attending physician, confirmed that given the resident's diagnoses and the dose of Dilaudid he had been receiving, missing 40 hours of medication would have caused significant pain. The Medical Director stated the pain could have been severe enough to cause the documented nausea.
Systemic Failures in Pain Management Protocols
The investigation uncovered multiple breakdowns in the facility's pain management system. When the Dilaudid ran out, nurses failed to: - Notify the attending physician about the medication shortage - Contact the on-call physician service for alternative orders - Alert hospice services about the gap in pain coverage - Utilize the facility's emergency medication kit (E-kit) which contained alternative pain medications
The facility maintained an emergency pharmacy kit specifically for such situations. According to interviews with medical staff, physicians could have ordered alternative narcotic pain medications like oxycodone or hydrocodone from this kit to provide relief while awaiting the Dilaudid delivery.
A nurse practitioner at the facility explained that standard procedure required immediate physician notification when pain medications were unavailable. She stated that had any provider been notified, "something could have been ordered from the facility's E-kit, and the provider could have inquired with the pharmacy what was causing the delay."
Additional Care Violations Discovered
Beyond the pain management failure, inspectors identified several other significant violations affecting resident care:
Medication and Nutrition Safety Failures: The facility failed to verify gastrostomy tube placement before administering medications and fluids to two residents, creating aspiration pneumonia risk. Nurses were observed flushing feeding tubes without checking placement or residual volume, potentially allowing fluids to enter residents' lungs if tubes became displaced.
Unaddressed Weight Loss: A diabetic resident lost 9% of body weight over five months without proper assessment of the cause. Despite the resident consuming 76-100% of meals, the facility failed to investigate why weight loss continued or develop an appropriate intervention plan.
Activity Program Deficiencies: A resident with Huntington's Disease who enjoyed church services and gospel music did not attend any religious activities during the review period, despite these being documented as "very important" to him. The resident required staff assistance to participate but was not provided adequate support.
PASARR Screening Failures: The facility failed to accurately complete mental health screenings for multiple residents, leaving diagnoses blank or incorrectly documenting conditions. One resident with a new psychotic disorder diagnosis waited 11 months for required Level II screening instead of the mandated 14 days.
Infection Control Violations: Nurses failed to wear required protective gowns when performing wound care on a resident under Enhanced Barrier Precautions, risking infection spread to other vulnerable residents.
Industry Standards for End-of-Life Care
Hospice care standards emphasize that pain control takes precedence over nearly all other medical considerations for terminally ill patients. The Medicare Conditions of Participation for hospices require that patients have access to pain medications 24 hours a day, seven days a week. Facilities accepting hospice patients must maintain systems to ensure continuous medication availability.
When medication supply issues arise, facilities should have multiple backup systems including emergency medication supplies, relationships with 24-hour pharmacies, and clear escalation procedures for obtaining physician orders for alternative medications. The 40-hour gap in pain medication availability demonstrated complete failure of these backup systems.
Pattern of Medication Management Issues
The Dilaudid shortage was not an isolated incident but part of a pattern of medication management problems. Nursing notes revealed the medication "has been reordered a few different times over the past week, but never came in." This indicates ongoing supply chain issues that facility leadership failed to address proactively.
The consultant pharmacist interviewed during the investigation emphasized that hospice residents should never go without pain medications during end-of-life care. Yet the facility's response to known supply problems was passive - repeatedly reordering without success rather than implementing alternative solutions.
Regulatory Consequences
These violations resulted in actual harm citations, the second-most serious level of deficiency in federal nursing home surveys. The pain management failure alone affected the facility's compliance with federal regulations requiring appropriate pain management services and notification of physicians about significant changes in resident condition.
The facility now faces potential penalties including fines, increased oversight, and possible suspension from Medicare and Medicaid programs if violations are not corrected. The Kentucky Department for Aging and Independent Living will conduct follow-up inspections to verify correction of all identified deficiencies.
For families with loved ones in nursing facilities, this case highlights critical questions to ask about pain management protocols, medication availability procedures, and backup systems for medication shortages. Regular communication with facility staff about pain levels and medication administration can help identify problems before they result in unnecessary suffering.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Vanceburg Rehab and Care, LLC from 2024-08-22 including all violations, facility responses, and corrective action plans.
💬 Join the Discussion
Comments are moderated. Please keep discussions respectful and relevant to nursing home care quality.